Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1295320.RAlIxoPCB5B1z2O_sBUQmSerDZwGcY747j8eO_-1PWP5Y130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1295320.RAlIxoPCB5B1z2O_sBUQmSerDZwGcY747j8eO_-1PWP5Y130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1295320.RAlIxoPCB5B1z2O_sBUQmSerDZwGcY747j8eO_-1PWP5Y130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1295320.RAlIxoPCB5B1z2O_sBUQmSerDZwGcY747j8eO_-1PWP5Y130_provenance.
- NP1295320.RAlIxoPCB5B1z2O_sBUQmSerDZwGcY747j8eO_-1PWP5Y130_assertion description "[SEREX technology combined with SSH method is an effective research strategy which can filter tumor antigen with high specific character; the corresponding autoantibodies of TM4SFl, ClD, TIZ, BARDI, FXRI, and OV-189 gene's recombinant antigen in serum can be regarded as the biomarkers which are used to diagnose ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1295320.RAlIxoPCB5B1z2O_sBUQmSerDZwGcY747j8eO_-1PWP5Y130_provenance.
- NP1295320.RAlIxoPCB5B1z2O_sBUQmSerDZwGcY747j8eO_-1PWP5Y130_assertion evidence source_evidence_literature NP1295320.RAlIxoPCB5B1z2O_sBUQmSerDZwGcY747j8eO_-1PWP5Y130_provenance.
- NP1295320.RAlIxoPCB5B1z2O_sBUQmSerDZwGcY747j8eO_-1PWP5Y130_assertion SIO_000772 26513889 NP1295320.RAlIxoPCB5B1z2O_sBUQmSerDZwGcY747j8eO_-1PWP5Y130_provenance.
- NP1295320.RAlIxoPCB5B1z2O_sBUQmSerDZwGcY747j8eO_-1PWP5Y130_assertion wasDerivedFrom befree-2016 NP1295320.RAlIxoPCB5B1z2O_sBUQmSerDZwGcY747j8eO_-1PWP5Y130_provenance.
- NP1295320.RAlIxoPCB5B1z2O_sBUQmSerDZwGcY747j8eO_-1PWP5Y130_assertion wasGeneratedBy ECO_0000203 NP1295320.RAlIxoPCB5B1z2O_sBUQmSerDZwGcY747j8eO_-1PWP5Y130_provenance.
- befree-2016 importedOn "2016-02-19" NP1295320.RAlIxoPCB5B1z2O_sBUQmSerDZwGcY747j8eO_-1PWP5Y130_provenance.